NCT03306940

Botulinum Toxin A in the Treatment of Hemifacial Spasm

Does Bilateral Botulinum Toxin A in Patients With Hemifacial Spasm Improve Facial Symmetry Unilateral and Bilateral Injection of Botulinum Toxin A in Patients With Hemifacial Spasm? A Prospective, Randomized, Controlled Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Tongji University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed follow-up A researcher record facial videos and analyzed facial symmetry and completed 3 scales.

Detailed description

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups.Patients of unilateral group were injected to the affected side and the dose of botulinum toxin A was 2.5-3.75 units/per site. Patients of bilateral group were injected to the affected side with dose of 2.5-3.75 units/per site and the normal side was injected with dose of 1.25 units/per site. 3 scales for measurement were used.

Conditions

• Hemifacial Spasm

Interventions

Type	Name	Description
DRUG	Botulinum Toxin Type A	patients were injected to the normal side with dose of 1.25 units/per site

Timeline

• Start date: 2017-10-02
• Primary completion: 2018-07-31
• Completion: 2018-08-31
• First posted: 2017-10-11
• Last updated: 2017-10-12

Locations

1 site across 1 country: China